In the face of new challenges to the access to testing, prevention, care and treatment necessary to stop HIV transmissions, infections, illnesses and deaths at home and globally, the theme of this year’s World AIDS Day: Ending the HIV/AIDS Epidemic: Resilience and Impact must drive the efforts ahead.

New evidence-based clinical practice guidelines for the prevention, diagnosis, and treatment of Lyme disease have been developed by a multidisciplinary panel led by the IDSA, the American Academy of Neurology, and the American College of Rheumatology. Representatives from an additional 12 medical specialties and patients also served on the panel.

A new evidence-based clinical practice guideline for the prevention, diagnosis and treatment of the worldwide disease caused by Babesia parasites has been published in Clinical Infectious Diseases. Providing current standards of diagnosis and management of human babesiosis, the 2020 Guideline on Diagnosis and Management of Babesiosis was developed by a multidisciplinary panel convened by IDSA.

Among the nine exceptional individuals being recognized by the Infectious Diseases Society of America, James D. Cherry, M.D., FIDSA, has been honored with this year’s Alexander Fleming Award for lifetime achievement. IDSA is pleased to acknowledge the following individuals for excellence in the field of infectious diseases with its annual Society Awards:

The four principles established by CDC’s Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine set a positive course for mitigating and containing the impacts of the pandemic.

A paper published Thursday in Clinical Infectious Diseases examines how barriers to appropriate diagnostic tools led to missed opportunities to curb antibiotic resistance and recommends steps to develop and expand the use of tests that can identify resistant bacteria.